CN1114190A - 高分子合成材料重睑术混合处理液 - Google Patents
高分子合成材料重睑术混合处理液 Download PDFInfo
- Publication number
- CN1114190A CN1114190A CN 94107007 CN94107007A CN1114190A CN 1114190 A CN1114190 A CN 1114190A CN 94107007 CN94107007 CN 94107007 CN 94107007 A CN94107007 A CN 94107007A CN 1114190 A CN1114190 A CN 1114190A
- Authority
- CN
- China
- Prior art keywords
- double
- synthetic material
- high molecular
- molecular synthetic
- treating liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及的是一种医药配制品，其每500ml盐水中含有肾上腺素1.5-2ml、地塞咪松8-10ml、普鲁卡因250-300ml、杜冷丁2-4ml。本发明将具有止血、消炎、麻醉、止痛功能的各种药物混配于一体，可以减化行术程序，减轻痛苦，防止感染，提高成功率。
Description
本发明涉及的是一种医药配制品，特别是一种含有有机有效成份的医药配制品。
在采用高分子合成材料行重睑术时，要将高分子合成材料置于眼皮内。为了确保手术的成功率，减少痛苦感和防止感染等，要进行一系列的处理过程。如果这些处理分别进行，将使操作规程复杂，引起感染、降低成功率。
本发明之目的在于提供一种可减化行术程序，降低病人痛苦，提高成功率的高分子合成材料重睑术处理液。
本发明之目的是这样实现的：每500ml无菌盐水中含有肾上腺素(2％)1.5～2ml、地塞咪松(2％)8～10ml、普鲁卡因250～300ml、杜冷丁2～4ml。
本发明之优点在于：将止血药物、消炎药物、止痛麻醉等药物混配成一体，一次注入行术部位，不仅可以减少术者之痛苦，而且可防止术中的出血和感染，术后能迅速消肿，手术成功率高。减化行术程序，提高行术效率。
下面举例对本发明作进一步描述：产品组成为：肾上腺素(2％)2ml、地塞咪松10ml、普鲁卡固250ml，杜冷丁4ml、无菌盐水500ml。将肾上腺素、地塞咪松、普鲁卡固和杜冷丁按份加入到盐水中混合均即可制成本发明的产品。
Claims (2)
1、一种高分子合成材料重睑术混合处理液，其特征是：每500ml盐水中含有肾上腺素1.5-2ml、地塞咪松8-10ml、普鲁卡因250-300ml、杜冷丁2-4ml。
2、根据权利要求1所述的高分子合成材料重睑术混合处理液，其特征是：每500ml盐水中含有肾上腺素2ml、地塞咪松10ml、普鲁卡因250ml、杜冷丁4ml。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94107007 CN1114190A (zh) | 1994-06-07 | 1994-06-07 | 高分子合成材料重睑术混合处理液 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94107007 CN1114190A (zh) | 1994-06-07 | 1994-06-07 | 高分子合成材料重睑术混合处理液 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1114190A true CN1114190A (zh) | 1996-01-03 |
Family
ID=5032754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 94107007 Pending CN1114190A (zh) | 1994-06-07 | 1994-06-07 | 高分子合成材料重睑术混合处理液 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1114190A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001045678A3 (de) * | 1999-12-21 | 2002-04-11 | Id Pharma Gmbh | Arzneimittel, verfahren zu dessen herstellung und dessen verwendung |
-
1994
- 1994-06-07 CN CN 94107007 patent/CN1114190A/zh active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001045678A3 (de) * | 1999-12-21 | 2002-04-11 | Id Pharma Gmbh | Arzneimittel, verfahren zu dessen herstellung und dessen verwendung |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL135712A (en) | Use of recombinant activated protein c in the manufacture of medicaments for treating or preventing acquired hypercoagulable states associated with sepsis | |
| BR0109336A (pt) | Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico | |
| CA2549550A1 (en) | Botulinum toxin therapy for skin disorders | |
| EP1658858A3 (en) | Use of botulinum toxin for the treatment of unstable bladder | |
| GEP20043216B (en) | Orally Administered Controlled Drug Delivery System | |
| CN1141929C (zh) | 药物制剂 | |
| MXPA02003495A (es) | Derivados de piridinio para el manejo de complicaciones vasculares diabeticas y relacionadas con la edad, proceso para su preparacion, y usos terapeuticos de los mismos. | |
| CN1114190A (zh) | 高分子合成材料重睑术混合处理液 | |
| CN1093923A (zh) | 创伤、溃疡速愈散 | |
| MXPA06014625A (es) | Composicion termo-gelante binaria. | |
| KR950702433A (ko) | Tcf-ii를 유효성분으로 하는 혈장 응고 정상화제 | |
| Humble et al. | Soft tissue augmentation using silicone: an historical review | |
| CN1058154C (zh) | 一种治疗痔的药物 | |
| CN1060380C (zh) | 治疗伤口愈合的药 | |
| CN1062736C (zh) | 烧伤外用乳浊液 | |
| GARTLAND et al. | Use of hyaluronidase in soft tissue injury and its influence on experimental bone repair | |
| KR20000056925A (ko) | 숯을 이용한 일반의약품인 파스 제조방법 | |
| CN1059322C (zh) | 高分子合成材料重睑术用聚丙烯的处理方法 | |
| CN1068499A (zh) | 中药制剂——正骨灵及其配制方法 | |
| CN1057684C (zh) | 一种杀菌消炎生肌外用药膏及其制造方法 | |
| HUT57057A (en) | Process for producing analgesic and antiflogistic pharmaceutical compositions | |
| CN1163144A (zh) | 一种治疗冻疮、疥疮的中药药水 | |
| KR930021212A (ko) | 봉독을 유효성분으로 하는 주사제 조성물 | |
| CN1022800C (zh) | 一种治疗鸡瘟药的制备方法 | |
| CN1108170C (zh) | 一种金葡液的缓冲液和带缓冲液的金葡液 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |